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ABSTRACT
Introduction: People with chronic epilepsy (PWE)
often make costly but clinically unnecessary emergency
department (ED) visits. Offering them and their carers
a self-management intervention that improves
confidence and ability to manage seizures may lead to
fewer visits. As no such intervention currently exists,
we describe a project to develop and pilot one.
Methods and analysis: To develop the intervention,
an existing group-based seizure management course
that has been offered by the Epilepsy Society within
the voluntary sector to a broader audience will be
adapted. Feedback from PWE, carers and
representatives from the main groups caring for PWE
will help refine the course so that it addresses the
needs of ED attendees. Its behaviour change potential
will also be optimised. A pilot randomised controlled
trial will then be completed. 80 PWE aged ≥16 who
have visited the ED in the prior 12 months on ≥2
occasions, along with one of their family members or
friends, will be recruited from three NHS EDs. Dyads
will be randomised to receive the intervention or
treatment as usual alone. The proposed primary
outcome is ED use in the 12 months following
randomisation. For the pilot, this will be measured
using routine hospital data. Secondary outcomes will
be measured by patients and carers completing
questionnaires 3, 6 and 12 months postrandomisation.
Rates of recruitment, retention and unblinding will be
calculated, along with the ED event rate in the control
group and an estimate of the intervention’s effect on
the outcome measures.
Ethics and dissemination: Ethical approval: NRES
Committee North West—Liverpool East (Reference
number 15/NW/0225). The project’s findings will
provide robust evidence on the acceptability of seizure
management training and on the optimal design of a
future definitive trial. The findings will be published in
peer-reviewed journals and presented at conferences.
Trial registration number: ISRCTN13 871 327.
INTRODUCTION
Emergency hospital use for epilepsy
With a prevalence of up to 1%,1 epilepsy is
one of the most common brain disorders in
the UK.2 As well as having signiﬁcant impli-
cations for the lives of patients,3 epilepsy also
has important societal impacts.4 5 Studies
show that one of these is the cost of provid-
ing emergency care.6–8
In the UK, one ﬁfth of people with epi-
lepsy (PWE) visit hospital emergency depart-
ments (ED) each year for seizures,6–8 with
rates being highest in socially deprived
areas.9 10 In England in 2012/2013, the cost
of providing emergency care for epilepsy was
>£56 million.11 One reason it is so high is
because half of the PWE visiting EDs are
Strengths and limitations of this study
▪ This will be the first study to develop and pilot
seizure first aid training for people with epilepsy
who frequently visit hospital emergency depart-
ments (EDs), and their carers.
▪ The intervention will be developed so that it
closely aligns with service users’ needs and pre-
ferences in order to maximise its acceptability
and benefit.
▪ Its method of delivery and low cost could mean
it holds the potential to be generalisable across
the health service and sustainable.
▪ The follow-up period in the pilot randomised con-
trolled trial will be 1 year and the data on the
primary outcome measure, namely subsequent ED
use, will be collected using objective hospital data.
▪ We expect that the pilot will provide robust esti-
mates to inform the optimal design of a future
definitive trial.
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admitted to hospital;8 12–14 indeed, 85% of admissions
for epilepsy occur on this unplanned basis.15
Readmissions further drive costs up;16 ≥60% of PWE
reattend ED within 12 months.17
Seeking emergency care for epilepsy can be important,
even life-saving. However, most ED visits by PWE are clinic-
ally unnecessary. The UK-wide National Audits of Seizure
Management in Hospitals (NASH)18 19 found that most
visits were by people with known rather than new epilepsy
and most had experienced uncomplicated seizures.
Guidelines are clear that, with the correct training, such
seizures can be safely managed by patients and their fam-
ilies within the community.20–22 Factors beyond clinical
need have been identiﬁed as often being important in
determining whether an emergency admission occurs,
which most likely explains why so many visits to the ED by
people in whom the diagnosis is clear and who have
made a full recovery still end in hospital admission.8 23
Reducing unnecessary emergency visits to hospital by
PWE has been identiﬁed as one way that resource-
limited health services can generate savings.24 Reducing
emergency visits is also important for service users. ED
visits can be inconvenient, distressing and do not typic-
ally lead to extra support.12 There may even be iatro-
genic harm, such as that associated with unnecessary
intravenous cannulations.25
Reasons for emergency hospital use
It has been challenging to know how to reduce emer-
gency visits for epilepsy,26 not least because the reason/s
for them were unclear. The association between seizure
frequency and ED use had, for example, been found to
only be modest in size and seizure type had not proved
a robust predictor.6 27–29
However, a recent mixed-methods study has brought
clarity to the issue.11 It suggests that what is often key in
determining whether someone visits the ED for seizures
is not necessarily clinical need, but conﬁdence in
seizure management.30 31 Eighty-ﬁve adults with epilepsy
were prospectively recruited from UK EDs and inter-
viewed. Patients fell into two groups. In the ﬁrst, there
were patients who reported high levels of conﬁdence.
Their views closely aligned with seizure ﬁrst aid guide-
lines. They had typically visited the ED only once in the
previous 12 months.
In contrast, patients in the second group did not feel
conﬁdent managing seizures and had typically made ≥2
ED visits in the prior year. They feared seizures, includ-
ing the possibility of death. This led them to call for an
ambulance when they believed they were about to have,
or had had, a seizure. Despite having diagnosed epilepsy
for ∼10 years, they said they had not received sufﬁcient
information about epilepsy.
Quantitative results from the project reinforced what
patients said. Regression analyses identiﬁed that it was a
patient’s score on a measure of perceived ‘mastery’ over
their epilepsy which signiﬁcantly predicted how many
ED visits they made over the subsequent 12-months
rather than seizure frequency.29 There was also evidence
of poor ﬁrst aid knowledge. One third of the sample
incorrectly stated that it was always necessary to call a
doctor or ambulance if a person with epilepsy has a
seizure, even if it occurs without complications.17 Only
11% of the wider epilepsy population believe this
(S Jarvie. Self perception and psychosocial functioning in
people with intractable epilepsy [PhD thesis, Unpublished
data]. University of Glasgow, 1993).
The above ﬁndings are in keeping with prior evidence.
Coping with life in the context of epilepsy requires PWE
to learn and adopt speciﬁc self-management behaviours
to prevent seizures and manage consequences. It is
known, however, that PWE typically receive little support
from health services in learning to self-manage.32–35
One consequence is that knowledge about epilepsy
among patients can be poor, especially in those with low
education.36 37
Another important ﬁnding from the interviews con-
ducted for the project was that when seizures occurred,
responsibility for patient care and the decision to seek
emergency care could be delegated to family or friends.
When these persons were conﬁdent in seizure manage-
ment and been correctly informed, the patient would
visit the ED only under certain circumstances. However,
when they were not, they would often seek emergency
medical care, regardless of clinical need: One said, “[I
was] just worried because I don’t know anything about
epilepsy… I mean I only know the bad things, I know it
can be quite serious… I know you can die… I was so
worried I decided just to ring an ambulance…better
safe than sorry.”30 This accords with evidence that most
seizures leading to the ED appear to occur within
patients’ homes and are often witnessed.13 38
Need for seizure first aid training
On the basis of the evidence presented, PWE who fre-
quently visit the ED might beneﬁt from a self-
management intervention that improves their own and
their informal carers’ conﬁdence and ability in man-
aging seizures and empowers them to be able to tell
others from their wider support network about ﬁrst aid.
No epilepsy self-management intervention is available
which focuses on seizure management, or on those
attending the ED, and none systematically involves
carers.39–41 That such an intervention might improve
seizure management skills is, however, supported by the
broader literature. Studies on general ﬁrst aid show that
even brief interventions can improve skills in a variety of
groups.42–46 Evidence from asthma studies is also import-
ant.47–49 Boyd et al47 reviewed 17 randomised controlled
trials (RCT) of educational interventions for children
(and parents) at risk of asthma-related ED attendances.
The interventions led to a 37% reduction in the relative
risk of reattendance at the ED and a 21% reduction in
subsequent hospital admissions.
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Aims
We describe here a project to develop and then pilot a
seizure ﬁrst aid training intervention for PWE who fre-
quently visit the ED and their carers (protocol V.1.1, 31/
3/15). This project will be completed in the Merseyside
area of North-West England.
Rather than creating an entirely new intervention, it
will be developed by adapting a promising seizure man-
agement course that already exists to address the needs
of PWE visiting the ED. The course titled ‘Epilepsy
awareness and seizure management’ has been offered
on a small scale within the third sector to people from a
variety of backgrounds, including patients, teachers and
care home staff by the UK charity, Epilepsy Society. The
society has offered the course since 1998 and given us
permission to adapt it. It has not been formally evalu-
ated, but aims to increase participants’ conﬁdence in
seizure management.
Changes to the existing course will be required since it
was developed for delivery to a narrower, fee-paying
group. It was not created for delivery within the health
service, nor for PWE who visit EDs who can be particu-
larly challenged by epilepsy and may have lower educa-
tion.9 17 27 36 37 Once adapted, a pilot RCT shall be
completed. A pilot is required to address uncertainties
about the optimal design of a full RCT.50 These include
intervention acceptability, likely effect, as well as partici-
pant uptake and retention.
Accordingly, the project’s objectives are to:
1. Optimise the content, delivery and behaviour change
potential of the existing course for PWE attending
the ED, and their informal carers. The resulting
adapted package will be named Seizure First Aid
Training.
2. Conduct a pilot RCT of Seizure First Aid Training
versus Treatment As Usual (TAU) alone to estimate
likely recruitment, consent and follow-up rates in a
future deﬁnitive trial.
3. Test acceptability of randomisation to participants.
4. Calculate estimates of the annual rate of ED visits in
the control group and the likely dispersion param-
eter to inform the sample size calculation of a future
RCT.
5. Conduct an analysis of the cost of implementing the
Seizure First Aid Training programme.
METHODS AND ANALYSIS
Part A: Intervention development (months 1–8)
Design
To adapt the existing course, three stages will be com-
pleted (ﬁgure 1).
Stage 1: Consultation with main professional groups
Leading representatives from the professional groups
supporting PWE will review the course materials and be
interviewed. Consensus exists on seizure ﬁrst aid22 and
so, where expertise permits, representatives will be asked
to identify changes needed to ensure accuracy, as well as
suggestions for improvement.
Stage 2: Optimisation of behaviour change potential
A signiﬁcant component of the intervention consists of
providing information about epilepsy, its manifestations
and ﬁrst aid. This will highlight to some participants
that their past behaviour conﬂicts with medical guid-
ance. This could be construed as a threat to self-
integrity.51–53 Self-Afﬁrmation theory states that people
are motivated to maintain self-integrity.53 Accordingly,
threats to the self can be defensively processed (eg,
motivated scepticism, unrealistic optimism). To mitigate
against this, Reed and Aspinwall’s self-afﬁrmation54
‘Kindness Questionnaire’ will be inserted to the begin-
ning of the intervention. Completing such an exercise is
known to reduce resistance to threatening or dissonant
information and increase behaviour change.55 56
Stage 3: Consultation with service user representatives
Health professionals and PWE may have different views
of support needed.57 For this reason, two courses using
the initial adaptation of the course will be run with
patient-carer dyads and focus groups will explore users’
views of the intervention, its content, the facilitator,
scheduling and acceptability.
Participants
For Stage 1, representatives from neurology, emergency
medicine, the ambulance service, nursing, general prac-
tice, user groups and health care commissioning based
within the UK have been identiﬁed, approached and will
be asked to provide informed consent. For Stage 3, user
groups within the Merseyside area will help identify and
recruit dyads. PWE will be eligible to participate if they
are aged ≥16 and have visited ED in the past 2 years. The
full inclusion/exclusion criteria are in table 1.
Intervention in its current form
The existing course lasts 3 h. It is delivered to groups of
10–20 people by an educational facilitator. It covers
eight topics (table 2) and emphasises how most seizures
are self-limiting. It seeks to provide participants with a
practical understanding of when seizures do, and do
not, require emergency treatment.
Course materials include standardised slides, videos
and an information pack. The pack provides participants
with a permanent record, as well as space for notes to
promote active processing. Participants are encouraged
to share experiences and ask questions. The course con-
sists of a number of components and so is a complex
intervention.50
Facilitators typically have a nursing or social care back-
ground, experience of working with PWE and follow a
local Epilepsy Society training programme in order to
deliver the course.
As well as holding the potential to increase seizure
management conﬁdence and lead to fewer unnecessary
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ED visits, further justiﬁcation for adapting this particular
course is that its delivery method could be generalisable.
Specialist epilepsy nurses and physiologists have been
asked to deliver broader self-management interven-
tions.39 59 Such staff are, however, not widely avail-
able.8 60 61 The epilepsy voluntary sector is particularly
well developed,26 62 63 and so commissioning third
sector organisations to deliver seizure-management train-
ing could help avoid shortfalls. The Epilepsy Society, for
example, currently has a bank of 12 educational facilita-
tors located around England able to deliver its courses,
and it already has a role in providing information mate-
rials for hospital clinics. The model could also be ﬁnan-
cially sustainable, with the Epilepsy Society charging
only £40 to attend its course.
Another reason for adapting this particular course is
that its content and format broadly align with service
users’ preferences, thus increasing its likely acceptability.
Studies show that PWE tend to want short, face-to-face
self-management courses, and for them to be delivered
by persons with knowledge or experience of epilepsy.64–68
Part B: Pilot RCT (months 9–38)
Design
Using the adapted seizure management course, a multi-
centre, external pilot RCT will be completed with PWE
aged ≥16 years who have visited the ED in the prior
12 months for epilepsy on ≥2 occasions, along with one
of their family members or friends who have an infor-
mal caring role. Patients and carers will be followed up
for 12 months. The participants and data ﬂow in the
study are shown in ﬁgure 2.
Participants
The EDs of three Merseyside NHS hospitals have been
recruited to identify potential participants. They serve a
population of ∼830 000 people, within which the preva-
lence of adult epilepsy is 0.98%.69 This population fea-
tures high levels of social deprivation70 71 and rates of
emergency admissions for epilepsy that are among the
highest.9
To identify eligible patients, the EDs will complete
searches of their electronic attendance records for
persons with a presentation/discharge code in the prior
12 months that is indicative of epilepsy. The eligibility
criteria are provided by table 2.
Invitation letters from the local consultant will be sent
to all ostensibly eligible patients. Those not opting out
of further contact within 3 weeks will be phoned by the
research team which will conﬁrm interest, verify eligibil-
ity and, if applicable, arrange an initial meeting. At that
meeting, consent will be obtained and baseline data col-
lected from the patient and their nominated family
member or friend.
Randomisation and concealment
Computer-generated randomisation of patient-carer
dyads will be completed remotely by the Clinical Trials
Research Centre (CTU) at the University of Liverpool
following consent and completion of the baseline
Figure 1 Intervention development process.
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measures. The unit of randomisation will be the individ-
ual participant and randomisation will be 1:1 between
the intervention and the control groups, stratiﬁed by
factors which at this stage will not be disclosed to
prevent treatment prediction.
The results of the allocation will be concealed from
the trial statistician and researchers responsible for
consent and data collection. A study administrator will
liaise with patients (and carers) to arrange attendance at
the intervention. Participants will be asked not to inform
the research team of their treatment allocation and we
shall test the success of blinding.
Interventions
Intervention arm: seizure first aid training (+TAU)
The intervention’s exact content will be determined in
Part A of the project. It is anticipated, however, that it
will continue to last ∼3 h, with no additional booster ses-
sions, and be delivered to groups of ∼10 patient-carer
dyads by local Epilepsy Society educational facilitators.
Courses will be delivered within educational rooms at
the local hospitals from where recruitment occurred.
Both patients and carers will be expected to participate
actively in the course. Participants will each be provided
with an information pack. These will include copies of
Table 1 Participant inclusion and exclusion criteria
Study
part Inclusion criteria Exclusion criteria
Part A—Intervention development
Patients ▸ Established diagnosis of epilepsy (≥1 year)
▸ All epilepsy syndromes and all types of focal and
generalised seizures
▸ Currently being prescribed antiepileptic medication
▸ Age ≥16 years (no upper age limit)
▸ Have visited ED in the past 2 years for epilepsy (as
reported by the patient)
▸ Live in the North West area of England
▸ Able to provide informed consent and participate in
intervention in English
▸ Acute symptomatic seizures related to acute
neurological illness or substance misuse
▸ Severe current psychiatric disorder (eg, acute
psychosis) or life-threatening medical illness
Carers ▸ A significant other to the patient (eg, family member,
friend) whom the patient identifies as providing informal
support
▸ Age ≥16 years (no upper age limit)
▸ Live in the North West area of England
▸ Able to provide informed consent and participate in
intervention in English
▸ Severe current psychiatric disorder or
life-threatening medical illness
Part B—Pilot RCT
Patients ▸ Established diagnosis of epilepsy (≥1 year)
▸ All epilepsy syndromes and all types of focal and
generalised seizures
▸ Currently being prescribed antiepileptic medication
▸ Age ≥16 years (no upper age limit)
▸ Visited an ED for epilepsy on ≥2 occasions within the
previous 12 months (as reported by patient)
▸ Live within 25 miles of any of the ED recruitment sites
▸ Able to provide informed consent, participate in
intervention and independently complete questionnaires
in English
▸ Actual or suspected psychogenic non-epileptic
seizures alone or in combination with epilepsy
▸ Acute symptomatic seizures related to acute
neurological illness or substance misuse
▸ Severe current psychiatric disorders (eg, acute
psychosis) or life-threatening medical illness
▸ Enrolled in other epilepsy related
non-pharmacological treatment studies
Carers ▸ A significant other to the patient (eg, family member,
friend) whom the patient identifies as providing informal
support
▸ Age ≥16 years (no upper age limit)
▸ Lives in the North West area of England
▸ Severe current psychiatric disorders or
life-threatening medical illness
▸ Enrolled in other epilepsy related
non-pharmacological treatment studies
While efforts will be made to maximise the recruitment of patient-carer dyads, patient participants will be permitted to take part without a
carer. Carers will not, however, be able to take part in this part of the project without a patient partner having at least consented to take part in
the study. Up to 90% of PWE can identify an informal carer.58
ED, emergency department PWE, people with chronic epilepsy; RCT, randomised controlled trial.
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the course material, certiﬁcates of attendance, epilepsy
identiﬁcation cards, wallet sized ﬁrst aid instruction
cards and contact details for further information.
Control arm: TAU only
The active intervention will be compared to TAU alone
by the PWE’s normal care team. No restrictions will be
placed on the services TAU participants can access.
In the UK, there is no accepted care for those with
established epilepsy who have visited an ED.26 All PWE
are, however, expected to have a medical review of their
epilepsy at least yearly by a generalist or specialist. When
seizures are not controlled or treatment fails, it is
expected that a patient will be referred to secondary or
tertiary services.26 The UK’s NASH showed that EDs ini-
tiate referral to neurology for only a third of PWE
attending the ED.18 19
Delayed access to the Seizure First Aid Training for
control participants is being used as a recruitment/
retention incentive. These courses will be run once all
retained patient and carer participants from both arms
have completed their ﬁnal follow-up assessments. The
TAU group will only contribute outcomes to the trial
data set under the TAU condition.
Outcomes and outcome measures
Primary
The proposed primary outcome measure for a future
deﬁnitive trial is the number of epilepsy-related ED visits
made over the 12 months following randomisation by
Table 2 Topics covered by existing version of a seizure
first aid training course
Topic Details
1. What is epilepsy? Myths and truths about epilepsy
are discussed, and a simple explanation is
provided of what happens in the brain to produce
seizures
2. Different causes of epilepsy and seizure triggers
3. Diagnosis: important diagnostic tools are
discussed
4. Detailed discussion of seizure types, their effects,
and how to manage each of them, including when
to call an ambulance and demonstration of the
recovery position. This includes video clips
showing different types of seizures, with PWE and
health professionals discussing them
5. Status epilepticus
6. Treatments: medication and side effects
7. Risk management and support needs
8. Sources of further information: addresses of
organisations offering assistance and information
Figure 2 Design of the pilot trial phase of the project. ED, emergency department PWE, people with chronic epilepsy.
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patient participants. This will be measured in the pilot
using routinely collected hospital data. The NHS’s
Hospital Episode Statistics system provides a record of
an individual’s use of all EDs in England and data will
be extracted from it to provide information on individ-
ual participants’ use of the ED at baseline and over
follow-up. While this system is increasing in sophistica-
tion, it does not currently have a code to indicate visits
related speciﬁcally to epilepsy. However, in order to
increase speciﬁcity and provide a more reasonable esti-
mate of such visits, we shall utilise a broader code that
does exist within the system so as to identify only visits
related to a central nervous system condition (excluding
stroke).
Secondary
Over the course of the trial, patient and carer partici-
pants will be required to each complete three sets of
questionnaires (table 3) either in a face-to-face interview
with a research worker (at baseline and at 12-month
follow-up) or through the post (at 6-month follow-up).
To encourage continued participation, we will offer each
participant a £10 voucher on completion of each
assessment.86
Secondary measures will be based on participant self-
report and be used to help estimate whether the inter-
vention leads to changes including improved quality of
life, conﬁdence managing seizures, knowledge of seizure
ﬁrst aid, as well as reductions in fear of seizures. Patient
participants will also be asked to self-report on their
service use, including of ED and ambulances. A full list
of the measures to be used is provided in table 3.
Participants will be requested to complete the mea-
sures prior to randomisation and then 6 and 12 months
postrandomisation. Baseline and 12 month follow-up
measures will be collected in face-to-face sessions by a
research worker, blind to treatment allocation. Estimated
completion time is 1 h. An abbreviated assessment will
occur at 6 months. For it, participants will be posted a
set of questionnaires for completion.
Statistical analysis
Since this is a pilot RCT, a formal power calculation is
not appropriate; the study will not be powered to detect
a clinically meaningful difference in the primary
outcome between the treatment groups. Rather, we aim
to generate the following: estimates of eligibility,
consent, recruitment and retention rates and speed of
recruitment; and estimates of completion rates of study
assessment tools and rates of unblinding. To accurately
inform a sample size calculation for a future deﬁnitive
trial, estimates of the ED event rate and dispersion par-
ameter will also be provided, along with summary statis-
tics measuring the effect of the intervention on the
Table 3 Self-reported secondary outcome measures by assessment and participant type
Outcome Participants Measure
Items
(n) Baseline 6-month 12-month
Knowledge and fear
of seizures
Patients;
carers
Epilepsy Knowledge and Management
Questionnaire—Fears subscale72
5 ✓ – ✓
Knowledge of what to
do when faced with a
seizure
Patients;
carers
Items from Thinking About Epilepsy
Questionnaire73
3 ✓ – ✓
Confidence
managing seizures/
epilepsy
Patients;
carers
Epilepsy Mastery Scale74 (P); Parents
Response to Child Illness Scale—
Condition Management subscale75(C)
6 ✓ ✓ ✓
Quality of life Patients Quality of Life in Epilepsy Scale-3176 31 ✓ ✓ ✓
Distress Patients;
carers
Hospital Anxiety and Depression Scale77 14 ✓ – ✓
Seizure control Patients At baseline, Thapar’s Seizure Frequency
Scale for the prior 12 months.78At
follow-up, patients will be asked for
number of seizures (of any type) since
the last assessment and dates of the first
and most recent*
1 ✓ ✓ ✓
Felt Stigma Patients;
carers
Stigma of Epilepsy Scale79 80 3 ✓ – ✓
Burden Carers Zarit Caregiver Burden Inventory81 22 ✓ ✓ ✓
Activation Patients;
carers
Patient Activation Measure82 13 ✓ – ✓
Health economics Patients Client Service Receipt Inventory83 and
EQ-5D 84
13 ✓ – ✓
Feedback on trial
participation
Patients;
carers
Adapted from Magpie Trial85 3 – – ✓
*To assist patients to be able to provide this information, they will be offered a seizure diary at their baseline appointment.
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primary and secondary outcome measures and the preci-
sion of such estimates.
Forty patients in each treatment arm will provide the
above estimates with adequate precision. In particular,
with a sample size of 80, we will be able to estimate an
overall dropout rate of 25% (approximate rate experi-
enced by similar studies11 39 40) to within a 95% CI of
±10% and a participation rate of 20% from an assumed
400 patients to within a 95% CI of ±4%. Assuming that
the ED data at 12 months is not available for 25% of
patients, outcome data from 60 patients would still allow
robust estimation of the ED rate and dispersion
parameter.87 88
Minimising bias
PWE will attend the course outside of their routine
clinic appointments and we do not expect transfer of
intervention-related knowledge (and therefore contam-
ination of the TAU group) between those in the inter-
vention and control arms at a single site. Bias will be
further minimised by restricting access to and availability
of the intervention materials. When participants are
asked to self-report on their service use, we shall also ask
those in the control group whether they accessed any
elements of the intervention.
DISCUSSION
Ethics and oversight
Monitoring by an independent Study Steering
Committee (SSC) will help to ensure that the rights,
safety and well-being of the participants are the most
important considerations. Compliance with Good
Clinical Practice and scientiﬁc integrity will be managed
by the study management team through regular and ad
hoc meetings. Guidelines from the project’s funder indi-
cates that a Data Monitoring and Ethics Committee is
not required (http://www.nets.nihr.ac.uk/__data/
assets/…/ssc-and-dmec-checklist-june13.doc).
Patients’ experience of unexpected serious adverse
events (SAE) within the trial phase will be monitored by
asking them to complete a standardised SAE checklist.
Patients will be asked to complete it by phone at 3 and
6 months postrandomisation, and in person at the
12-month follow-up appointment. A neurologist will
assess unexpected SAEs, and the approving ethics com-
mittee and sponsor will be informed within 15 days of
any SAEs that are judged to be related to participation.
Given the population, the following will not be deemed
as unexpected SAEs: epileptic seizures with or without
injury; visits to the ED where the stay lasts <24 h; side
effects of antiepileptic medication; or diagnosis of a
comorbid psychiatric condition.
For the trial phase, the CTU will provide regular
reports on data quality to ensure the integrity of ran-
domisation, to monitor the level of missing data and the
timeliness of data entry and to check for illogical or
inconsistent data. Data collection procedures will be
monitored and source data veriﬁcation against the
paper data collection forms undertaken at regular
intervals.
Recruitment for studies involving serial assessments
can be low. Owing to the social impact of epilepsy and
its comorbidity, recruitment of PWE can also be challen-
ging.89 For the project, only patients and carers provid-
ing signed, informed consent will be able to participate.
However, to maximise uptake, we shall utilise an ‘opt
out’ method of inviting patients, rather than the trad-
itional ‘opt in’ approach. Speciﬁcally, a letter, signed by
the ED consultant, will be sent to all ostensibly eligible
individuals explaining the study and inviting them to
participate. Persons will be informed that unless they opt
out (by email, telephone or using a FREEPOST response
slip) within 3 weeks, it will be taken that they are inter-
ested in being telephoned by the research team with
further information.
The approach is ethically justiﬁable.90 It signiﬁcantly
increases participation rates,91 reduces the likelihood of
a biased sample of participants being recruited,92 and is
more cost-effective compared to an ‘opt in’ approach.93
We are currently using a version of the opt-out approach
for another trial with PWE and the approach has proved
largely acceptable.59
Dissemination
Despite the demonstrated need, there has been inad-
equate attention given to implementing and evaluating
interventions to increase seizure management conﬁ-
dence in PWE who visit ED and their informal carers.
We have described a study that will develop such an
intervention for use within the UK health service. The
trial phase aims to provide design information for a
future deﬁnitive trial and quantitative estimates of the
impact of the intervention on patients in terms of its
clinical and cost-effectiveness. We will use the ﬁndings to
inform the development of a future deﬁnitive RCT, with
the ultimate goal of reducing clinically unnecessary ED
use and improving the well-being of PWE who visit ED
and their carers.
Author affiliations
1Department of Psychological Sciences, University of Liverpool, Liverpool, UK
2Department of Molecular and Clinical Pharmacology, University of Liverpool,
Liverpool, UK
3Department of Biostatistics, University of Liverpool, Liverpool, UK
4Institute of Pharmaceutical Science, King’s College London, Liverpool, UK
5Centre for Health Economics & Medicines Evaluation, Bangor University,
Bangor, UK
6School of Health and Related Research, University of Sheffield, Sheffield, UK
7Department of Basic and Clinical Neuroscience, King’s College London,
London, UK
Acknowledgements The authors would like to thank the Epilepsy Society for
the role that they will have in this project and NHS England for their support
with the trial phase. They would like to express appreciation for the
contributions from people with epilepsy and their family members and friends
who will participate in this study. The study sponsor is the University of
Liverpool (reference: UoL001108; sponsor@liv.ac.uk).
8 Noble AJ, et al. BMJ Open 2015;5:e009040. doi:10.1136/bmjopen-2015-009040
Open Access
Contributors AJN and LR conceived of the study and designed it together
with AGM, CT-S, DH, MM and SG. CT-S planned the statistical analysis. AJN
wrote the manuscript, with revisions being made by LR, AGM, CT-S, DAH,
MM and SG. All authors read and approved the final manuscript.
Funding This project is being funded by the National Institute for Health
Research’s Health Services and Delivery Research (HS&DR) Programme
(project number 14/19/09). The views and opinions expressed herein are
those of the authors and do not necessarily reflect those of the University of
Liverpool, the HS&DR programme, the NIHR, the NHS or the Department of
Health.
Competing interests None declared.
Ethics approval NRES Committee North West—Liverpool East, reference
number 15/NW/0225.
Provenance and peer review Not commissioned; peer reviewed for ethical
and funding approval prior to submission.
Data sharing statement No additional data are available.
Study status The study is currently in the intervention development phase.
The results of the project will be available in 2018.
Open Access This is an Open Access article distributed in accordance with
the terms of the Creative Commons Attribution (CC BY 4.0) license, which
permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: http://
creativecommons.org/licenses/by/4.0/
REFERENCES
1. Ridsdale L, Charlton J, Ashworth M, et al. Epilepsy mortality and risk
factors for death in epilepsy: a population-based study. Br J Gen
Pract 2011;61:e271–8.
2. MacDonald BK, Cockerell OC, Sander JW, et al. The incidence and
lifetime prevalence of neurological disorders in a prospective
community-based study in the UK. Brain 2000;123:665–76.
3. ILAE/IBE/WHO Global Campaign Against Epilepsy (2010). Epilepsy
in the WHO European region: Fostering epilepsy care in Europe.
Stichting Epilepsie Instellingen: Hoofddorp.
4. Organization WH. The global burden of disease: 2004 Update.
Geneva: WHO, 2008.
5. Pugliatti M, Beghi E, Forsgren L, et al. Estimating the cost of
epilepsy in Europe: a review with economic modeling. Epilepsia
2007;48:2224–33.
6. Jacoby A, Buck D, Baker G, et al. Uptake and costs of care for
epilepsy: findings from a U.K. regional study. Epilepsia
1998;39:776–86.
7. Hart YM, Shorvon SD. The nature of epilepsy in the general
population. II. Medical care. Epilepsy Res 1995;21:51–8.
8. Kitson A, Shorvon S. Clinical Standards Advisory Group. Services
for patients with epilepsy: a report of a CSAG Committee. London:
Department of Health, 2000.
9. NHS Right Care. The NHS atlas of variation in healthcare. 2010.
www.rightcare.nhs.uk/atlas/qipp_nhsAtlas-LOW_261110c.pdf
10. Shohet C, Yelloly J, Bingham P, et al. The association between the
quality of epilepsy management in primary care, general practice
population deprivation status and epilepsy-related emergency
hospitalisations. Seizure 2007;16:351–5.
11. Ridsdale L, McCrone P, Morgan M, et al. Can an epilepsy nurse
specialist-led self-management intervention reduce attendance at
emergency departments and promote well-being for people with
severe epilepsy? A non-randomised trial with a nested qualitative
phase. Health Services and Delivery Research 2013;1.
12. Dixon PA, Kirkham JJ, Marson AG, et al. National Audit of Seizure
management in Hospitals (NASH): results of the national audit of
adult epilepsy in the UK. BMJ Open 2015;5:e007325.
13. Reuber M, Hattingh L, Goulding PJ. Epileptological emergencies in
accident and emergency: a survey at St James’s university hospital,
Leeds. Seizure 2000;9:216–20.
14. Ryan J, Nash S, Lyndon J. Epilepsy in the accident and emergency
department—developing a code of safe practice for adult patients.
South East and South West Thames Accident and Emergency
Specialty Sub-committees. J Accid Emerg Med 1998;15:237–43.
15. Bruce M, Griffiths C, Brock A. Trends in mortality and hospital
admissions associated with epilepsy in England and Wales during
the 1990s. Health Stat Q 2004;21:23–9.
16. Whiston S, Coyle B, Chappel D. Health needs assessment for long
term neurological conditions in North East England. Stockton on
Tees: North East Public Health Observatory, 2009.
17. Noble AJ, Goldstein LH, Seed P, et al. Characteristics of people with
epilepsy who attend emergency departments: prospective study of
metropolitan hospital attendees. Epilepsia 2012;53:1820–8.
18. Pearson M, Marson T, Dixon P, et al. National Audit of Seizure
Management in Hospitals: St Elsewhere’s Clinical Report. 2012.
19. Pearson M, Marson T, Dixon P, et al. National Audit of Seizure
Management in Hospitals: St Elsewhere’s Clinical Report. 2014.
20. National Society for Epilepsy. When to dial 999. Secondary When to
dial 999. 2012. http://www.epilepsysociety.org.uk/AboutEpilepsy/
Firstaid/Whentodial999
21. British Epilepsy Association. What to do when someone has a
seizure. Secondary What to do when someone has a seizure. 2013.
https://www.epilepsy.org.uk/info/firstaid
22. NHS Choices. What to do if someone has a seizure (fit). Secondary
What to do if someone has a seizure (fit). 2013. http://www.nhs.uk/
Livewell/Epilepsy/Pages/Ifyouseeaseizure.aspx
23. O’Cathain A, Knowles E, Turner J, et al. Explaining variation in
emergency admissions: a mixed-methods study of emergency
and urgent care systems. Health Serv Del Res 2014;2(48).
24. Department of Health. The NHS Outcomes Framework 2013/14.
2012. https://www.gov.uk/government/uploads/system/uploads/
attachment_data/file/213055/121109-NHS-Outcomes-Framework-
2013-14.pdf
25. Limm EI, Fang X, Dendle C, et al. Half of all peripheral intravenous
lines in an Australian tertiary emergency department are unused:
pain with no gain? Ann Emerg Med 2013;62:521–5.
26. National Institute for Health and Care Excellence. The epilepsies:
the diagnosis and management of the epilepsies in adults and
children in primary and secondary care. NICE clinical guideline
137, 2012.
27. Bautista RE, Glen ET, Wludyka PS, et al. Factors associated with
utilization of healthcare resources among epilepsy patients. Epilepsy
Res 2008;79:120–9.
28. Cramer JA, Blum D, Fanning K, et al. The impact of comorbid
depression on health resource utilization in a community sample of
people with epilepsy. Epilepsy Behav 2004;5:337–42.
29. Noble AJ, McCrone P, Seed PT, et al. Clinical- and
cost-effectiveness of a nurse led self-management intervention to
reduce emergency visits by people with epilepsy. PLoS ONE
2014;9:e90789.
30. Ridsdale L, Virdi C, Noble A, et al. Explanations given by people
with epilepsy for using emergency medical services: a qualitative
study. Epilepsy Behav 2012;25:529–33.
31. Noble AJ, Morgan M, Virdi C, et al. A nurse-led self-management
intervention for people who attend emergency departments with
epilepsy: the patients’ view. J Neurol 2013;260:1022–30.
32. Gilliam F, Penovich PE, Eagan CA, et al. Conversations between
community-based neurologists and patients with epilepsy: results
of an observational linguistic study. Epilepsy Behav 2009;16:
315–20.
33. Jain P, Patterson VH, Morrow JI. What people with epilepsy want
from a hospital clinic. Seizure 1993;2:75–8.
34. Goldstein LH, Minchin L, Stubbs P, et al. Are what people know
about their epilepsy and what they want from an epilepsy service
related? Seizure 1997;6:435–42.
35. Ridsdale L, Morgan M, O’Connor C. Promoting self-care in epilepsy:
the views of patients on the advice they had received from
specialists, family doctors and an epilepsy nurse. Patient Educ
Couns 1999;37:43–7.
36. Ridsdale L, Kwan I, Cryer C. The effect of a special nurse on
patients’ knowledge of epilepsy and their emotional state. Epilepsy
Evaluation Care Group. Br J Gen Pract 1999;49:285–9.
37. Ridsdale L, Kwan I, Cryer C. Newly diagnosed epilepsy: can nurse
specialists help? A randomized controlled trial. Epilepsy Care
Evaluation Group. Epilepsia 2000;41:1014–19.
38. Hunt N, Touquet VL. Known epileptic patients brought to the
accident and emergency department. J R Coll Gen Pract
1986;36:224–5.
39. Bradley PM, Lindsay B. Care delivery and self-management
strategies for adults with epilepsy. Cochrane Database Syst Rev
2008;(1):CD006244.
40. Ramaratnam S, Baker GA, Goldstein LH. Psychological treatments
for epilepsy. Cochrane Database Syst Rev 2008;(3):CD002029.
41. Lindsay B, Bradley PM. Care delivery and self-management
strategies for children with epilepsy. Cochrane Database Syst Rev
2010;(12):CD006245.
42. Pelinka LE, Thierbach AR, Reuter S, et al. Bystander trauma care—
effect of the level of training. Resuscitation 2004;61:289–96.
Noble AJ, et al. BMJ Open 2015;5:e009040. doi:10.1136/bmjopen-2015-009040 9
Open Access
43. Murad MK, Husum H. Trained lay first responders reduce trauma
mortality: a controlled study of rural trauma in Iraq. Prehosp Disaster
Med 2010;25:533–9.
44. Kano M, Siegel JM, Bourque LB. First-aid training and capabilities of
the lay public: a potential alternative source of emergency medical
assistance following a natural disaster. Disasters 2005;29:58–74.
45. Plant N, Taylor K. How best to teach CPR to schoolchildren:
a systematic review. Resuscitation 2013;84:415–21.
46. Oliver E, Cooper J, McKinney D. Can first aid training encourage
individuals’ propensity to act in an emergency situation? A pilot
study. Emerg Med J 2014;31:518–20.
47. Boyd M, Lasserson TJ, McKean MC, et al. Interventions for
educating children who are at risk of asthma-related emergency
department attendance. Cochrane Database Syst Rev 2009;(2):
CD001290.
48. Gibson PG, Powell H, Coughlan J, et al. Limited (information only)
patient education programs for adults with asthma. Cochrane
Database Syst Rev 2002(2):CD001005.
49. Tapp S, Lasserson TJ, Rowe B. Education interventions for adults
who attend the emergency room for acute asthma. Cochrane
Database Syst Rev 2007;(3):CD003000.
50. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating
complex interventions: the new Medical Research Council guidance.
BMJ 2008;337:a1655.
51. Baumeister RF. Self-regulation and ego-threat: motivated cognition,
self-deception, and destruction in goal setting. In: Gollwitzer PM,
Bargh JA, eds. The psychology of action: linking cognition and
motivation to behavior. New York: Guilford Press, 1996:
27–47.
52. Schüz N, Schüz B, Eid M. When risk communication backfires:
randomized controlled trial on self-affirmation and reactance to
personalized risk feedback in high-risk individuals. Health Psychol
2013;32:561–70.
53. Steele CM. The psychology of self-affirmation: sustaining the
integrity of the self. In: Berkowitz L, ed. Advances in experimental
social psychology. New York: Academic Press, 1988:261–302.
54. Reed MB, Aspinwall LG. Self-affirmation reduces biased processing
of health-risk information. Motiv Emotion 1998;22:99–132.
55. Cohen GL, Sherman DK. The psychology of change: self-affirmation
and social psychological intervention. Annu Rev Psychol
2014;65:333–71.
56. Epton T, Harris PR. Self-affirmation promotes health behavior
change. Health Psychol 2008;27:746–52.
57. Johnson EC, Fraser RT, Miller JW, et al. A comparison of epilepsy
self-management needs: Provider and patient perspectives. Epilepsy
Behav 2012;25:150–5.
58. Walker ER, Bamps Y, Burdett A, et al. Social support for
self-management behaviors among people with epilepsy: a content
analysis of the WebEase program. Epilepsy Behav 2012;23:285–90.
59. Kralj-Hans I, Goldstein LH, Noble AJ, et al. Self-Management
education for adults with poorly controlled epILEpsy (SMILE (UK)):
a randomised controlled trial protocol. BMC Neurol 2014;14:69.
60. Epilepsy Action. A critical time for epilepsy in England. A study of
epilepsy service provision in England Leeds. British Epilepsy
Association, 2013.
61. Epilepsy Action. Best care: the value of epilepsy specialist nurses.
Leeds: British Epilepsy Association, 2010.
62. Brown SW, Besag FMC. United Kingdom. In: Engel J, Pedley TA,
eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott,
Williams & Wilkins, 2008:2915–20.
63. Dua T, de Boer HM, Prilipko LL, et al. Epilepsy Care in the World:
results of an ILAE/IBE/WHO Global Campaign Against Epilepsy
survey. Epilepsia 2006;47:1225–31.
64. Fraser RT, Johnson EK, Miller JW, et al. Managing epilepsy well:
self-management needs assessment. Epilepsy Behav
2011;20:291–8.
65. Choi-Kwon S, Yoon SM, Choi MR, et al. The difference in
perceptions of educational need between epilepsy patients and
medical personnel. Epilepsia 2001;42:785–9.
66. Elliott JO, Shneker BF. A health literacy assessment of the epilepsy.
com website. Seizure 2009;18:434–9.
67. Pramuka M, Hendrickson R, Van Cott AC. Survey results of Internet
and computer usage in veterans with epilepsy. Epilepsy Behav
2010;17:366–8.
68. Kendall S, Thompson D, Couldridge L. The information needs of
carers of adults diagnosed with epilepsy. Seizure 2004;13:499–508.
69. Health & Social Care Information Centre. Quality and Outcomes
Framework (QOF) for April 2012-March 2013, England. 2013.
http://www.hscic.gov.uk/catalogue/PUB12262
70. Department of Health. Health Profile 2012 Liverpool. 2012.
www.apho.org.uk/resource/view.aspx?RID=117032
71. Department of Health. Health Profile 2012 Wirral. 2012. www.apho.
org.uk/resource/item.aspx?RID=117035
72. Mittan R. Fear of seizures. In: Whitman S, Hermann B, eds.
Psychopathology in epilepsy: social dimensions. New York: Oxford
University Press, 1986:90–121.
73. Martiniuk AL, Speechley KN, Secco M, et al. Development and
psyhometric properties of the Thinking about Epilepsy questionnaire
assesing children’s knowledge and attitudes about epilepsy.
Epilepsy Behav 2007;10:595–603.
74. Wagner AK, Keller SD, Kosinski M, et al. Advances in methods for
assessing the impact of epilepsy and antiepileptic drug therapy on
patients’ health-related quality of life. Qual Life Res 1995;4:115–34.
75. Shore CP, Austin JK, Dunn DW. Maternal adaptation to a child’s
epilepsy. Epilepsy Behav 2004;5:557–68.
76. Cramer JA, Perrine K, Devinsky O, et al. Development and
cross-cultural translations of a 31-item quality of life in epilepsy
inventory. Epilepsia 1998;39:81–8.
77. Zigmond AS, Snaith RP. The hospital anxiety and depression scale.
Acta Psychiatr Scand 1983;67:361–70.
78. Thapar A, Kerr M, Harold G. Stress, anxiety, depression, and
epilepsy: investigating the relationship between psychological factors
and seizures. Epilepsy Behav 2009;14:134–40.
79. Jacoby A. Felt versus enacted stigma: a concept revisited: evidence
from a study of people with epilepsy in remission. Soc Sci Med
1994;38:269–74.
80. Taylor J, Baker GA, Jacoby A. Levels of epilepsy stigma in an
incident population and associated factors. Epilepsy Behav
2011;21:255–60.
81. Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired
elderly: correlates of feelings of burden. Gerontologist
1980;20:649–55.
82. Hibbard JH, Mahoney ER, Stockard J, et al. Development and
Testing of a Short Form of the Patient Activation Measure. Health
Serv Res 2005;40:1918–30.
83. Beecham J, Knapp M. Costing psychiatric interventions. In:
Thornicroft G, Brewin C, Wing J, eds. Measuring mental health
needs. London: Gaskell, 1992:163–83.
84. Williams A. The role of the EUROQOL instrument in QALY
calculations. York: Centre for Health Economics, University of York,
1995.
85. Smyth RM, Duley L, Jacoby A, et al. Women’s experiences of
participating in the Magpie Trial: a postal survey in the United
Kingdom. Birth 2009;36:220–9.
86. Brueton VC, Tierney J, Stenning S, et al. Strategies to improve
retention in randomised trials. Cochrane Database Syst Rev
2013;12:MR000032.
87. Sim J, Lewis M. The size of a pilot study for a clinical trial should be
calculated in relation to considerations of precision and efficiency.
J Clin Epidemiol 2012;65:301–8.
88. Julious SA. Sample size of 12 per group rule of thumb for a pilot
study. Pharm Stat 2005;4:287–91.
89. Noble AJ, Goldstein LH, Seed P, et al. The characteristics of
emergency attendees for epilepsy in London hospitals. World
Congress of Neurology; Morocco, 2011.
90. Vellinga A, Cormican M, Hanahoe B, et al. Opt-out as an acceptable
method of obtaining consent in medical research: a short report.
BMC Med Res Methodol 2011;11:40.
91. Travena L, Irwig L, Barratt A. Impact of privacy legislation on the
number and characteristics of people who are recruited for research:
a randomised controlled trial. J Med Ethics 2006;8:477.
92. Junghans C, Feder G, Hemingway H, et al. Recruiting patients to
medical research: double blind randomised trial of “opt-in” versus
“opt-out” strategies. BMJ 2005;331:940.
93. Schroy PC III, Glick JT, Robinson P, et al. A cost-effectiveness
analysis of subject recruitment strategies in the HIPAA era: results
from a colorectal cancer screening adherence trial. Clin Trials
2009;6:597–609.
10 Noble AJ, et al. BMJ Open 2015;5:e009040. doi:10.1136/bmjopen-2015-009040
Open Access
